Income Statement (TTM)
Sabaa International Company for Pharmaceutical and Chemical Industry Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 70 | 70 | 60 | 66 | 61 | 45 | 37 | 25 | 20 | 18 | 19 | 17 | 13 | 13 | 12 | 13 | 16 | 23 | 33 | 43 |
| Change (%) | -0.57 | -14.26 | 9.89 | -7.54 | -25.27 | -18.50 | -31.53 | -19.66 | -10.63 | 1.85 | -6.59 | -26.56 | 4.65 | -6.75 | 3.03 | 21.69 | 46.40 | 44.39 | 32.13 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 29 | 30 | 23 | 30 | 31 | 27 | 23 | 10 | 9 | 11 | 11 | 13 | 9 | 4 | 4 | 4 | 9 | 20 | 26 | 26 |
| Change (%) | 4.94 | -23.22 | 32.05 | 2.88 | -14.85 | -15.53 | -53.53 | -9.32 | 14.70 | 3.86 | 16.58 | -35.27 | -58.89 | 4.93 | 2.34 | 131.80 | 128.29 | 31.33 | 0.86 | |
| % of Revenue | 40.79 | 43.05 | 38.55 | 46.32 | 51.54 | 58.72 | 60.86 | 41.31 | 46.62 | 59.83 | 61.01 | 76.14 | 67.11 | 26.37 | 29.67 | 29.47 | 56.13 | 87.53 | 79.62 | 60.77 |
| Gross Operating Profit | 42 | 40 | 37 | 35 | 29 | 19 | 14 | 15 | 11 | 7 | 7 | 4 | 4 | 10 | 9 | 9 | 7 | 3 | 7 | 17 |
| Change (%) | -4.37 | -7.48 | -4.00 | -16.53 | -36.35 | -22.73 | 2.69 | -26.94 | -32.74 | -1.14 | -42.83 | 1.25 | 134.27 | -10.94 | 3.33 | -24.31 | -58.38 | 136.00 | 154.26 | |
| % of Revenue | 59.21 | 56.95 | 61.45 | 53.68 | 48.46 | 41.28 | 39.14 | 58.69 | 53.38 | 40.17 | 38.99 | 23.86 | 32.89 | 73.63 | 70.33 | 70.53 | 43.87 | 12.47 | 20.38 | 39.23 |
| SG&A | 18 | 20 | 18 | 14 | 12 | 10 | 8 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 13 | 13 | 12 |
| Change (%) | 8.22 | -9.33 | -19.78 | -18.42 | -14.42 | -20.47 | -7.95 | 2.30 | -22.77 | 8.50 | 1.92 | -0.07 | 2.69 | -2.82 | 5.30 | 0.82 | 89.66 | 1.72 | -4.64 | |
| % of Revenue | 25.68 | 27.96 | 29.56 | 21.58 | 19.04 | 21.80 | 21.28 | 28.60 | 36.42 | 31.47 | 33.52 | 36.58 | 49.77 | 48.84 | 50.90 | 52.02 | 43.09 | 55.83 | 39.33 | 28.38 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 52 | 50 | 41 | 45 | 43 | 37 | 30 | 18 | 17 | 17 | 18 | 20 | 15 | 10 | 10 | 10 | 15 | 34 | 40 | 40 |
| Change (%) | -4.91 | -17.75 | 9.55 | -3.89 | -14.73 | -16.86 | -41.72 | -4.56 | -1.73 | 5.46 | 11.38 | -23.85 | -32.97 | -0.24 | 4.23 | 48.46 | 118.73 | 19.26 | -0.94 | |
| % of Revenue | 74.24 | 71.00 | 68.11 | 67.89 | 70.58 | 80.52 | 82.14 | 69.91 | 83.04 | 91.30 | 94.54 | 112.72 | 116.88 | 74.87 | 80.10 | 81.03 | 98.85 | 147.68 | 121.98 | 91.46 |
| Operating Income | 18 | 20 | 19 | 21 | 18 | 9 | 7 | 8 | 3 | 2 | 1 | -2 | -2 | 3 | 2 | 2 | 0 | -11 | -7 | 4 |
| Change (%) | 11.93 | -5.70 | 10.63 | -15.26 | -50.54 | -25.26 | 15.37 | -54.72 | -54.17 | -36.01 | -317.42 | -2.53 | -255.83 | -26.15 | -1.79 | -92.62 | -6,165.36 | -33.43 | -151.34 | |
| % of Revenue | 25.76 | 29.00 | 31.89 | 32.11 | 29.42 | 19.48 | 17.86 | 30.09 | 16.96 | 8.70 | 5.46 | -12.72 | -16.88 | 25.13 | 19.90 | 18.97 | 1.15 | -47.68 | -21.98 | 8.54 |
| Interest Expense | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 |
| Change (%) | -8.97 | 11.49 | 34.27 | -0.09 | -34.09 | -5.59 | -21.61 | 37.79 | 59.97 | 12.03 | 20.04 | -10.01 | -18.88 | -8.11 | -9.93 | 5.75 | 31.51 | 29.18 | 22.45 | |
| % of Revenue | -1.04 | -0.95 | -1.24 | -1.51 | -1.63 | -1.44 | -1.67 | -1.91 | -3.27 | -5.86 | -6.44 | -8.28 | -10.15 | -7.87 | -7.75 | -6.78 | -5.89 | -5.29 | -4.73 | -4.39 |
| Net Income | 13 | 15 | 14 | 16 | 13 | 7 | 5 | 6 | 2 | 0 | -1 | -4 | -4 | 1 | -8 | -8 | -10 | -18 | -6 | 5 |
| Change (%) | 12.46 | -6.23 | 11.18 | -15.80 | -48.98 | -25.10 | 17.73 | -59.54 | -99.25 | -3,409.35 | 604.63 | 3.01 | -126.56 | -749.29 | 4.77 | 25.58 | 82.64 | -64.05 | -182.32 | |
| % of Revenue | 19.19 | 21.71 | 23.74 | 24.02 | 21.87 | 14.93 | 13.72 | 23.59 | 11.88 | 0.10 | -3.23 | -24.40 | -34.22 | 8.69 | -60.49 | -61.51 | -63.48 | -79.19 | -19.71 | 12.28 |
Source: Capital IQ
